The global insulin delivery devices market, worth $9,499.1 million in 2014, is expected to grow at a CAGR of 7.0% during 2015-2020. The insulin syringes segment held the largest share of 33% in the global insulin delivery devices market; whereas, the insulin pump was the fastest growing segment in the same year. The insulin pump market is escalating with high growth rate due to several factors such as technological advancements in insulin pumps to maintain the level of insulin in the body, increasing awareness of diabetes, and increasing prevalence of diabetes. Rising awareness of diabetes have been imparting positive impact on insulin delivery devices market, as people are increasingly adopting new technology to maintain insulin level in body and experience better results from the delivery devices.

Browse Full Report Visit –

Diabetes is a chronic disease caused due to insufficient production or inappropriate use of insulin in the body. Insulin in delivered with the help of various delivery devices, such as insulin pumps, pen injectors, insulin syringe and jet injectors. The insulin syringes are most commonly used delivery systems for self-medication. However, for some people insulin syringe is not convenient option, which resulted in development of other devices for the treatment of diabetes. Insulin pens and pumps have various advantages, which help in delivering accurate dosage of insulin and maintain the normal level of insulin in body. Usage of insulin pen in administering insulin is less time-consuming compared to the usage of syringes and vials.

The increasing awareness of diabetes across the globe through campaigns, conferences and activities is creating awareness about the long term effects and complications of diabetes, encouraging people to enter regular diabetes checkups. Moreover, obesity is caused due to diet imbalance, leading to various risk factors for Type 2 diabetes, high blood pressure, heart disease and other health problems. Risk factors of Type 2 diabetes and high blood pressure are increasing steadily with rise in prevalence of obesity, which is consequently driving the growth of the insulin delivery device market.

The prevalence of diabetes is also increasing every year. It is one of the leading causes of death and has increased risk of developing number of serious health problems. It is the major cause of cardiovascular disease, kidney disease, eye disorders and stroke. Also, increase in geriatric population is also driving the growth of the global insulin delivery device market.

Browse All Reports of This Category –

The restraints associated with insulin delivery devices market include high insulin analogue cost and hazards and risks associated with the drug delivery devices. The insulin pen needle is for single use, although many diabetic patients re-use needle for delivery of insulin. The re-use of needle could lead to bacterial growth on the needle, risk of lipohypertrophy and risk of breaking fine tip of needle. Similarly, the risk associated with jet injectors are accuracy of insulin dosage and improper injection. Improper injection of insulin can lead to altered absorption level of insulin in the blood stream and bruising. However, limited number of insulin producers and high price variation in different countries impedes the growth of the market.

The key companies operating in the global insulin delivery device market include Medtronic, Inc., F. Hoffmann-La Roche, Ltd., Abbott Laboratories Inc. Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Becton Dickinson and Company, Insulet Corporation, B. Braun Melsungen AG, Animas Corporation, and Ypsomed Holdings AG.

Report Coverage

  • Provides comprehensive understanding of the market with the help of informed market outlook, opportunities, challenges, trends, size and growth, competitive analysis, major competitors and Porter analysis
  • Identifies the key drivers of growth and challenges of the key industry players. Also, assesses the future impact of the propellants and restraints on the market
    Uncovers potential demands in the market
  • Porter analysis identifies competitive forces within the market
  • Provides information on the historical and current market size and the future potential of the market
  • Provides sizes of key regional markets using yardsticks of processes, segments, products, end user and technology, etc (as applicable)
  • Highlights the competitive scenario of the market, major competitors, market share, benchmarking, investments and merger acquisitions
  • Provides profiles of major competitors of the market including details of their operations, product and services, recent developments and key financial metrics.
  • Profiles provide better understanding of competition as well as the demands of the market

Purchase a Copy Of This Report –

Scope of Report

This research offers actual historical market size (2011 – 2014) and forecast market size (2015 – 2020) of the global insulin delivery devices market in the U.S. dollars.


  • By Type – Insulin Syringes, Insulin Pumps, Insulin Pen, Insulin Jet Injectors and Others
  • By Region – North America, Europe, Asia and Rest of World

For Technology News :
About – Acute Market Reports :

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email :
Website :